Bharat biotech’s Covid-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial

New Delhi: The Drugs Controller General of India (DCGI) on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions, officials said. A subject expert committee on Covid-19 at…

Covid : India’s active cases below 7 lakh after 21-day decline

New Delhi : India’s active Covid cases went below the 7-lakh mark on Thursday as the downtrend continued for the 21st day running, with the number of discharged patients outstripping fresh…

Anti-parasitic drug ivermectin not to be included for Covid-19 treatment protocol: Health Ministry

New Delhi: The Union Health Ministry has decided not to include ivermectin medicine (anti-parasitic drug) in the National Clinical Management Protocol for Covid-19 for the treatment of virus-infected patients. The move comes after the Central government’s…

FSSAI out to Campaign against Menace of Adulterated Khoa

New Delhi: Adulteration of Khoa, the main ingredient of many a sweet in India is all pervading. So names of sweets like Barfies, Pedas, milk cake , Kalakand and Halwas…

Coronavirus vaccine update: Chinese vaccine shows positive results, US govt probes Vaxart’s tall claims

The International Monetary Fund (IMF) has said that international cooperation on a coronavirus vaccine could boost the global economy by $9 trillion to pull it out of the economic crisis.…

Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments

One of the world’s biggest trials of COVID-19 therapies released its long-awaited interim results yesterday—and they’re a letdown. None of the four treatments in the Solidarity trial, which enrolled more…

HMD’s Syringes are ‘Weapons of Mass Vaccination’ in UNICEF’s COVID Armamentarium

New Delhi: When world war against COVID 19 begins, HMD (Hindustan Syringes & Medical Devices) will be one of the most dependable suppliers of auto disable syringes. Millions of its…

Apollo Hospitals ready to cater to COVID 19 aftermath

New Delhi: The Apollo Hospitals Group today announced the launch of Post-COVID Recovery Clinics across the hospital network. The Post-COVID Recovery Clinics will address the rising number of patients who…

To stem Food Fraud, FSSAI’s Compliance System is now pan India

New Delhi: FSSAI, the food regulator of India is intent on ensuring food safety uniformly. To that end, it has decided to extend its upgraded compliance system FoSCoS to pan…

Iodine based I2Cure – Bioshield 99.9% Effective against Coronavirus

New Delhi: In the time of the global pandemic, I2Cure launched their BioShield in India which is a research of Dr. Jack Kessler (Father of I2) an FDA Compliant, ISO…